References
- Hamet P. Cancer and hypertension: an unresolved issue. Hypertension 1996; 28: 321–324
- Working Party M. R. C. Medical Research Council trial of treatment of hypertension in older adults: principal results. B. M. J. 1992; 304: 405–412
- Olsen J. H. Commentary:Interpretation in drug epidemiology. Lancet 1998; 352: 162–163
- Isles C. G., Walker L. M., Beevers D. G., et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J. Hypertension 1986; 4: 141–156
- Hole D. J., Gillis C. R., McCallum I. R., et al. Cancer risk of hypertensive patients taking calcium antagonists. J Hypertension 1998; 16: 119–124
- Joussens J. V., Geboers J. Nutrition and gastric cancer. Proc. Nutr. Soc. 1981; 40: 37–46
- Dyer A. R., Berkson D. M., Stamler J., et al. High blood pressure: a risk factor for cancer mortality?. Lancet 1975; 1: 1051–1056
- Khaw K-T., Barrett-Connor E. Systolic blood pressure and cancer mortality in an elderly population. Amer. J. Epidemiol. 1984; 120: 550–558
- Goldbourt U., Holtzman E., Yaari S., et al. Elevated systolic blood pressure as a predictor of long-term cancer mortality: analysis by site and histologic subtype in 10,000 middle-aged and elderly men. J. N. C. L. 1986; 77: 63–70
- Wannamethee G., Shaper A. G. Blood pressure and cancer in middle-aged British men. Int. J. Epidemiol. 1996; 25: 22–31
- Lindop G. B. M., Leckie B. J., Mimran A. Renin—secreting tumours. The renin-angiotensin-system, JIS Robertson, GM Nicholls. Gower Medical Publishing, London 1993; 54
- Hole D. J., Hawthorne B. M., Isles C. G., et al. Incidence of and mortality from cancer in hypertensive patients. B. M. J. 1993; 306: 609–611
- Lever A. F., Hole D. J., Gillis C. R., et al. Do inhibitors of angiotensin I converting enzyme protect against risk of cancer?. Lancet 1998; 352: 179–184
- Pahor M., Guralnik J. M., Salive M. E., et al. Do calcium channel blockers increase the risk of cancer?. Amer. J. Hypertension 1996; 9: 695–699
- Pahor M., Guralnik J. M., Ferrucci L., et al. Calcium channel blockers and incidence of cancer in aged populations. Lancet 1996; 348: 493–497
- Jick H., Jick S., Derby L. E., et al. Calcium channel blockers and risk of cancer. Lancet 1997; 349: 525–528
- Olsen J. H., Sorensen H. T., Friis S., et al. Cancer risk in users of calcium channel blockers. Hypertension 1997; 29: 1091–1094
- Rosenberg L., Rao R. S., Palmer J. R., et al. Calcium channel blockers and the risk of cancer. J. A. M. A. 1998; 279: 1000–1004
- Volpert O. V., Ward W. F., Lingen M. W., et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J. Clin. Invest. 1996; 98: 671–679
- Hii S-I, Nicol D. L., Gotley B. C., et al. Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma. Brit. J. Cancer 1998; 77: 880–883